EPISODE · Aug 16, 2017 · 25 MIN
Episode 007: Medicine in 140 Characters: Digital KOLs
from The Syneos Health Podcast · host Jeffrey Stewart, Nick Lapolla, Madeline Rounds
Channels of influence in pharma have expanded from the traditional offline sphere of publications, trials, conference activities and others to include a vast new digital landscape that is shaping the way we need to interact with a new generation of key opinion leaders -- so-called "digital" KOLs. Digital KOLs have an "omnipresent" digital footprint that can include social media, independent websites, healthcare professional discussion platforms like SERMO and Doximity and a seemingly endless number of other potential channels. So what does this mean for those trying to find and reach out to these key influencers? Nick Lapolla, Manager, KOL Market Research at inVentiv Health Research and Insights and Madeline Rounds, Consultant on the inVentiv Health Medical Communications team, discuss how KOL mapping in this new age is both easier and harder than it used to be, highlight best practices and tactics and explain why it's still necessary to keep a human element in the mix. The information, data, and other content contained in this podcast and any associated articles, sponsorships, advertisements, announcements or other communications are provided for informational purposes only and should not be construed as professional advice of any kind, on any subject matter. The content of the podcast contains general information and may not reflect current legal developments, verdicts or settlements. Moreover, the content is not guaranteed to be complete, correct, timely, current or otherwise up-to-date. inVentiv Health reserves the right to make alterations or deletions to the content at any time without notice to you. inVentiv Health and its subsidiaries expressly disclaim all liability in respect to actions taken or not taken based on any or all of the podcast content. The information, data and other content contained in this podcast is not a reflection of, endorsed by or otherwise affiliated with, nor should it be attributed to, any of inVentiv Health's clients, customers or other contacts.The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you’re hearing? Be sure to rate and review us! We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [email protected].
What this episode covers
Channels of influence in pharma have expanded from the traditional offline sphere of publications, trials, conference activities and others to include a vast new digital landscape that is shaping the way we need to interact with a new generation of key opinion leaders -- so-called "digital" KOLs. Digital KOLs have an "omnipresent" digital footprint that can include social media, independent websites, healthcare professional discussion platforms like SERMO and Doximity and a seemingly endless...
NOW PLAYING
Episode 007: Medicine in 140 Characters: Digital KOLs
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m